New knee pain drug enters human testing
Symptom relief
Not yet recruiting
This early-stage study tests a drug called CX-011 for moderate to severe knee osteoarthritis pain. About 72 adults aged 18-75 with knee osteoarthritis will receive the drug via injection into the knee joint. The main goals are to check safety and tolerability, and to see if it re…
Phase: PHASE1, PHASE2 • Sponsor: CarthroniX, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC